Industry News

PLSG Invests $99,960 to Develop "Tissue Glue" for Use in Wide Range of Medical Applications

Published on 2004-09-20. Author : SpecialChem

Pittsburgh -- The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership putting the region's life sciences industry on a fast track for growth, announced it has invested $99,960 to support University of Pittsburgh researchers working to develop a form of "Tissue Glue" that would be used as a tissue adhesive to complement traditional tissue suturing techniques. The PLSG investment, which is provided under the Technology Development Fund (TDF) program, will be matched.

Researchers Michael Buckley, Ph.D., and Eric Beckman, Ph.D., have developed a novel lysine-derived urethane for use as a tissue adhesive. They are working to complete development of the adhesive which will adhere to tissue during surgical procedures, setting within minutes and degrading into non-toxic elements within two weeks of surgery.

The TDF program is designed to help accelerate the development of research-based projects which could be the genesis of new companies to be established regionally; or very early stage company-based projects which require key proof of concept or feasibility studies to allow attraction of angel, pre-seed or other investment funds.

"Tissue Glue promises to help improve and ease the recovery process for patients, minimizing the trauma, scar tissue build-up and inflammation commonly associated with invasive surgery," said Doros Platika, M.D., President and Chief Executive Officer of the PLSG. "The potential beneficiaries of Tissue Glue technology could number in the millions of people who receive countless numbers of outpatient and surgical procedures each year."

About the Technology Development Fund (TDF)

The Technology Development Fund is a competitive funding program designed to increase the commercialization potential of life science technologies developed by the region's scientists and entrepreneurs. The intent is to provide financial support to verify the technical and commercial feasibility of early stage inventions that will accelerate and increase the likelihood that the technology will be successfully commercialized through a regional start-up company. It is expected that proposals will contain a combination of technical and business tasks. These funds can be used in conjunction with or to leverage other early sources of funding.

About the PLSG

The Pittsburgh Life Sciences Greenhouse is a public/private partnership, founded by the University of Pittsburgh, Carnegie Mellon University, UPMC Health System, the Commonwealth of Pennsylvania and its regional foundation community. Together with private industry and advanced research and healthcare capabilities of our institutional partners, PLSG invests in and supports the growth of regional life sciences companies in the areas of: bioinformatics; bionanotechnology; diagnostics; medical devices; medical robotics; therapeutics; and tools and services.

Source: Pittsburgh Life Sciences Greenhouse (PLSG)

Improve your performance with water soluble epoxy compounds
Naphthenic Oils For Better Adhesion
Back to Top